Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2025
0mins
Should l Buy SES?
Source: Benzinga
Precision BioSciences Stock Surge: Shares of Precision BioSciences rose 10.8% to $5.58 in pre-market trading after the U.S. FDA cleared its investigational new drug application for PBGENE-HBV, aimed at treating chronic hepatitis B.
Pre-Market Trading Highlights: Several stocks experienced significant movements in pre-market trading, with notable gainers including NanoVibronix (up 42.3%) and Lytus Technologies (up 36.7%), while losers included Fold Holdings (down 18.8%) and Incyte Corporation (down 15.3%).
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SES?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SES
Wall Street analysts forecast SES stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.160
Low
4.00
Averages
4.00
High
4.00
Current: 1.160
Low
4.00
Averages
4.00
High
4.00
About SES
SES AI Corporation is a battery manufacturing company. The Company is a developer and manufacturer of high-performance, artificial intelligence (AI)-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility, drones, robotics, Battery Energy Storage Systems and other applications. It utilizes AI across the spectrum of its business, from research and development; materials sourcing; cell design; engineering and manufacturing; to battery health and safety monitoring. The Company's differentiated battery technology is designed to combine the high energy density of Li-Metal with the manufacturability of conventional Li-ion batteries. It produces large 50 Amp-hour (Ah) and 100Ah B-sample Li-Metal battery cells for EVs. Its AI programs fall under three major categories: AI for Science, AI for Manufacturing, and AI for Safety. The Company also specializes in premium energy storage systems.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Initiation: Rosen Law Firm has filed a class action lawsuit against SES AI Corporation on behalf of securities purchasers from January 29, 2025, to March 4, 2026, highlighting investor concerns over the company's financial transparency and accountability.
- Compensation Opportunity: Eligible investors in the class action may receive compensation without any upfront costs, which reduces the financial burden on investors and encourages broader participation from affected parties.
- Allegations of False Statements: The lawsuit alleges that SES AI made materially false and misleading statements during the class period, overstating expected results from deals with companies with limited operations, leading to investor losses when the truth emerged, thereby impacting the company's reputation and future financing capabilities.
- Law Firm's Credibility: Rosen Law Firm is recognized for its successful track record in securities class actions, having achieved the largest settlement against a Chinese company, which underscores its expertise and resource advantages in handling such cases, thereby enhancing investor confidence in their representation.
See More
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against SES AI Corporation for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between January 29, 2025, and March 4, 2026, with a deadline to contact the firm by June 26, 2026, to participate.
- False Statement Allegations: The complaint alleges that SES made false and misleading statements during the class period, particularly overstating the potential results of deals with companies lacking substantial operations, leading to significant investor losses once the truth emerged.
- Market Reaction Impact: Following the revelation of SES's misleading public statements, investor losses increased markedly, indicating serious deficiencies in the company's disclosure practices that could negatively affect its future stock price and investor confidence.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations to affected investors, encouraging them to understand their rights, demonstrating the firm's commitment to protecting shareholder interests while providing legal support for potential class action participation.
See More
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into SES AI Corporation (NYSE: SES) due to allegations that Barclays may have issued materially misleading business information, potentially exposing shareholders to securities claims.
- Stock Price Impact: On March 5, 2026, SES AI's stock plummeted by 36.8% after the company provided a 2026 revenue outlook that fell short of Wall Street expectations, resulting in significant losses for investors and prompting legal action.
- Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for affected investors, with a contingency fee arrangement that allows participation without upfront costs, thereby lowering the barrier for investors to join the lawsuit.
- Law Firm Credentials: Known for its successful track record in securities class actions, Rosen Law Firm recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resource capabilities in handling such cases effectively.
See More
- Significant Revenue Growth: SES AI's Q1 revenue reached $6.7 million, representing a 47% increase over the previous quarter, indicating strong market performance, with full-year 2026 revenue guidance reaffirmed between $30 million and $35 million, reflecting robust potential across all business units.
- Executive Transition: CFO Jing will transition from her role effective April 27, with Ray Liu appointed as the new CFO, a strategic move aimed at enhancing financial management and ensuring the company remains agile and competitive in a rapidly changing market environment.
- North American Market Entry: The company has successfully entered the North American market through a three-year distribution agreement valued at approximately $20 million with ATG EPower, a strategic initiative expected to provide new revenue streams and strengthen SES AI's market position.
- Manufacturing Line Conversion Completed: SES AI has completed the conversion of its manufacturing line at the Chungju, South Korea facility from EV pouch cells to drone-format pouch cells, with NDAA-compliant cells expected to begin shipping to defense and commercial drone customers in Q2, further driving growth in emerging markets.
See More
- Earnings Performance Beat: SES AI's Q1 non-GAAP EPS of $0.03 exceeded expectations by $0.06, indicating an improvement in profitability that boosts investor confidence in the company's financial health.
- Significant Revenue Growth: The company reported Q1 revenue of $6.7 million, surpassing forecasts by $3.05 million, demonstrating strong sales growth amid rising market demand, which could drive future investments and expansion.
- Gross Margin Improvement: Q1 gross margin increased to 18.1% from 11.3% in Q4 2025, reflecting successful cost control and operational efficiency, thereby enhancing the overall financial stability of the company.
- Cautious Outlook: While SES AI maintains a positive outlook for 2026, increased risks have led to a rating downgrade, prompting investors to monitor future market dynamics and the company's strategic responses to ensure sustained growth.
See More









